Amryt Pharma co-founder welcomes 'transformational' Aegerion acquisition

13th September 2019

https://otp.investis.com/clients/uk/amryt_pharmaceuticals_dac1/rns/regulatory-story.aspx?cid=1375&newsid=1218097